15/12/2025
Bone Marrow Transplant (BMT) in Nigeria: Hope, Reality, and the Power of Prevention
In recent years, Bone Marrow Transplant (BMT) has gained attention as a curative option for Sickle Cell Disorder (SCD). This growing awareness is good news, especially the great accomplishment attained by Sickle Cell Foundation, Nigeria (SCFN) in partnership with Lagos University Teaching Hospital (LUTH) in bringing to Nigeria, a world class access to BMT. However, it is equally important to balance hope with reality, especially in a country like Nigeria where SCD remains a major public health challenge.
It is no longer news that Nigeria has the highest burden of Sickle Cell Disorder globally with estimates of between 4 to 6 million people affected. This article highlights the progress Nigeria has made with BMT, its benefits and limitations, and why prevention through informed genotype choices remains the most practical solution.
1. A Brief History of Bone Marrow Transplant in Nigeria
Nigeriaās journey with Bone Marrow Transplant began quietly but significantly at the University of Benin Teaching Hospital (UBTH). UBTH made history by successfully performing Nigeriaās first bone marrow transplant for a patient with Sickle Cell Disorder, proving that such a complex procedure could be done locally.
This milestone opened the door for further development of transplant medicine in the country.
More recently, a landmark breakthrough came through the partnership between LUTH and SCFN. This collaboration brought structure, world-class expertise, and advocacy together, making BMT more visible and more accessible within Nigeria than ever before. It is the result of years of hard work, resilience and untold commitment to the cause of Sickle Cell Disorder for over three decades.
For the first time, Nigerians living with SCD can realistically look within the country for a potential cure rather than facing the financial and emotional burden of traveling abroad.
This news expectedly was met with mixed reactions. For some, it has brought hope that suggests that finally, one can choose a spouse without the limitations of genotype incompatibility while for others, the burden of the huge cost of BMT is not soul-lifting considering the fact that this is not affordable for an average Nigerian. It is important that we balance hope with reality, hence this write-up.
2. The Pros: Why This Is Good News
The LUTH/SCFN partnership represents real hope, especially for people already living with Sickle Cell Disorder.
Key benefits include:
Access to a potential cure within Nigeria
Reduced need for expensive medical travel abroad. The goal of LUTH/SCFN partnership is to reduce the cost of the procedure by 60% compared to going abroad.
Availability of specialized care from renowned medical professionals/experts from different parts of the world.
Renewed hope for families who have battled SCD for years
For individuals with severe complications, BMT replaces faulty stem cells with healthy ones thereby bringing an end to frequent crises, organ damage, or poor quality of life, BMT can mean freedom from pain, hospital admissions, and lifelong medications. This is massive.
This progress shows that Nigeriaās healthcare system can handle advanced treatments when given the right support.
3. The Cons: The Reality We Must Not Ignore
Despite the progress, Bone Marrow Transplant is not a simple or widely affordable solution.
Major challenges include:
High Cost
A bone marrow transplant in Nigeria can cost several millions of naira, depending on complications and length of care.
For the average Nigerian family, this cost is simply out of reach.
Need for a Suitable Donor
BMT requires a closely matched donor, usually a sibling. Unfortunately, many patients do not have a compatible donor, making the procedure impossible regardless of funds.
Target Patients
This focuses on children and young adults who generally have better outcomes.
Complex Process
Bone marrow transplant is not a one-day procedure. It involves:
Extensive testing and preparation
Chemotherapy to destroy existing bone marrow
Long hospital stays
Like every other procedure, chances of some complications must be factored in. It must be emphasised however that with state-of-the-art stem cell processing lab and post-transplant clinic in place, risks of complications are reduced to the barest minimum.
Lifelong follow-up in some cases.
These realities lead to one unavoidable truth:
Prevention is still better and far cheaper than cure.
4. Why Prevention Still Matters Most
While BMT offers hope for those living with Sickle Cell Disorder, those yet to marry or birth children must still seek to ensure genotype compatibility, go for genetic counselling and take necessary precautions to prevent further birth of babies with SS or SC genotypes.
The most effective, affordable, and sustainable solution remains informed genotype decision-making:
Knowing your genotype early
Understanding compatibility before marriage
Making choices that prevent bringing children into a lifetime of avoidable pain
No cure, no matter how advanced, is cheaper than preventing Sickle Cell Disorder from occurring in the first place.
5. Conclusion: Hope with Responsibility
The availability of Bone Marrow Transplant in Nigeria is great news for those already living with Sickle Cell Disorder. It brings hope closer to home and reduces dependence on foreign medical systems.
At the same time, this progress should encourage:
Government to provide subsidies and health insurance coverage
Corporate organizations to fund transplants through CSR initiatives
NGOs and foundations to support patients who qualify but cannot afford the cost
BMT is a breakthrough, but prevention remains our strongest weapon.
Akintunde Nathaniel MD, MPH
Director, Bethesda Sickle Cell Foundation (BSCF)
Tomiwa Akintunde